NDC 0169-4314

RYBELSUS

Oral Semaglutide

RYBELSUS is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Semaglutide.

Product ID0169-4314_27f15fac-7d98-4114-a2ec-92494a91da98
NDC0169-4314
Product TypeHuman Prescription Drug
Proprietary NameRYBELSUS
Generic NameOral Semaglutide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-09-20
Marketing CategoryNDA / NDA
Application NumberNDA213051
Labeler NameNovo Nordisk
Substance NameSEMAGLUTIDE
Active Ingredient Strength14 mg/1
Pharm ClassesGLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0169-4314-13

3 BLISTER PACK in 1 CARTON (0169-4314-13) > 10 TABLET in 1 BLISTER PACK (0169-4314-01)
Marketing Start Date2019-09-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0169-4314-13 [00169431413]

RYBELSUS TABLET
Marketing CategoryNDA
Application NumberNDA213051
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-09-20

NDC 0169-4314-01 [00169431401]

RYBELSUS TABLET
Marketing CategoryNDA
Application NumberNDA213051
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-09-20

Drug Details

Active Ingredients

IngredientStrength
SEMAGLUTIDE14 mg/1

OpenFDA Data

SPL SET ID:27f15fac-7d98-4114-a2ec-92494a91da98
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2200656
  • 2200654
  • 2200652
  • 2200650
  • 2200658
  • 2200644
  • Pharmacological Class

    • GLP-1 Receptor Agonist [EPC]
    • Glucagon-Like Peptide 1 [CS]
    • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

    NDC Crossover Matching brand name "RYBELSUS" or generic name "Oral Semaglutide"

    NDCBrand NameGeneric Name
    0169-4303RYBELSUSOral Semaglutide
    0169-4307RYBELSUSOral Semaglutide
    0169-4314RYBELSUSOral Semaglutide

    Trademark Results [RYBELSUS]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RYBELSUS
    RYBELSUS
    79242284 5682853 Live/Registered
    Novo Nordisk A/S
    2018-07-09

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.